| Literature DB >> 25268752 |
Phoenix Kit Han Mo1, Winnie Wing Sze Mak2, Eddie Siu Kwan Chong3, Hanyang Shen4, Rebecca Yuen Man Cheung5.
Abstract
OBJECTIVES: Screening is useful in reducing cancer incidence and mortality. People with severe mental illness (PSMI) are vulnerable to cancer as they are exposed to higher levels of cancer risks. Little is known about PSMI's cancer screening behavior and associated factors. The present study examined the utilization of breast, cervical, prostate, and colorectal cancer screening among PSMI in Hong Kong and to identify factors associated with their screening behaviors.Entities:
Mesh:
Year: 2014 PMID: 25268752 PMCID: PMC4182090 DOI: 10.1371/journal.pone.0107237
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Background Characteristics of the Participants.
| Background characteristics | Total (n = 591) |
| Gender | |
| Male | 266 (45.0%) |
| Female | 325 (54.0%) |
| Age | |
| <20 | 5 (0.9%) |
| 20–30 | 33 (5.8%) |
| 30–40 | 113 (19.7%) |
| 40–50 | 183 (31.9%) |
| 50–60 | 185 (32.3%) |
| 60–70 | 49 (8.6%) |
| >70 | 5 (0.8%) |
| Education level | |
| Primary School or below | 139 (23.6%) |
| Secondary School | 405 (68.9%) |
| College or above | 44 (7.5%) |
| Marital Status | |
| Single | 320 (54.3%) |
| Married/Cohabited | 133 (22.6%) |
| Divorced/Separated/Widowed | 136 (23.1%) |
| Employment Status | |
| Unemployed | 195 (33.1%) |
| Employed | 394 (66.9%) |
| Monthly income | |
| HKD4000 or below | 456 (79.2%) |
| HKD4000–8000 | 109 (18.9%) |
| HKD8000 above | 11 (1.9%) |
| Type of mental illness | |
| Schizophrenia | 286 (48.7%) |
| Depression | 131 (22.3%) |
| Bipolar Disorder | 35 (6.0%) |
| Others | 135 (23.0%) |
| Duration of mental illness (in years) | M = 17.7, SD = 10.9 |
Total number varied slightly for each variable due to missing data.
Cancer Screening Behavior among People with Severe Mental Illness.
| Cancer screening behavior | Total |
| Mammography screening (Women aged ≥40; n = 236) | |
| Ever had a screening | 49 (20.8%) |
| Never had a screening | 187 (79.3%) |
| How long since the last time mammography? (Among those who had mammography; n = 49) | |
| Within 1 year (≤1 year) | 17 (34.7%) |
| Within 2 years (>1 year but ≤2 years) | 13 (26.5%) |
| Within 3 years (>2 years but ≤3 years) | 6 (12.2%) |
| Within 5 years (>3 years but ≤5 years) | 3 (6.1%) |
| Over 5 years | 9 (18.4%) |
| Don't know/remember | 1 (2.0%) |
| Clinical breast examination (CBE) (Women aged ≥20; n = 310) | |
| Ever had a screening | 113 (36.5%) |
| Never had a screening | 197 (63.5%) |
| How long since the last time CBE? (Among those who had CBE; n = 113) | |
| Within 1 year (≤1 year) | 47 (41.6%) |
| Within 2 years (>1 year but≤2 years) | 16 (14.2) |
| Within 3 years (>2 years but≤3 years) | 13 (11.5%) |
| Within 5 years (>3 years but≤5 years) | 14 (12.4%) |
| Over 5 years | 22 (19.5%) |
| Don't know/remember | 1 (0.9%) |
| Pap-smear Test (Women aged 21 to 65; n = 304) | |
| Ever had a screening | 123 (40.5%) |
| Never had a screening | 181 (59.5%) |
| How long since the last time Pap-smear test? (Among those who had pap-smear test; n = 123) | |
| Within 1 year (< = 1 year) | 49 (39.8%) |
| Within 2 years (>1 year but ≤2 years) | 26 (21.1%) |
| Within 3 years (>2 years but ≤3 years) | 14 (11.4%) |
| Within 5 years (>3 years but ≤5 years) | 16 (13.0%) |
| Over 5 years | 18 (14.6%) |
| Prostate Examination (Men aged ≥50; n = 109) | |
| Ever had a screening | 14 (12.8%) |
| Never had a screening | 95 (87.1%) |
| Colorectal cancer screening (Men and women aged ≥50; n = 236) | |
| Ever had a screening | 51 (21.6%) |
| Never had a screening | 185 (78.4%) |
| Type of colorectal cancer screening taken (Among those who had colorectal cancer screening; n = 87) | |
| Fecal occult blood test | 26 (29.9%) |
| Flexible sigmoidoscopy | 15 (17.2%) |
| Colonoscopy | 30 (34.5%) |
| Double contrast barium enema | 16 (18.4%) |
The age for each cancer screening was set based on the screening guidelines of the American Cancer Society.
Total number higher than the number of people having taken colorectal cancer screening as some participants have taken more than one type of colorectal cancer screening.
Cancer Screening Behavior Reported in Other Studies.
|
| ||||||
| Study | Current study | Abdullah et al. | Kwok et al. | Kwok et al. | Ma et al. | Breen et al. |
| Country | Hong Kong | Hong Kong | Hong Kong | Australia | United States | United States |
| Targeted population | Chinese women with MI ≥40 years | Chinese women aged 31–50 years | Chinese women aged 50–69 years | Chinese-Australian women aged 50–69 years | Chinese-American women ≥40 years | Women ≥40 years |
| Sample size | 236 | 430 | 150 | 104 | NA | 10,374 |
| Screening rate | 20.8% | 28% | 32.7% | 75.0% | 79.9% | 66.9% |
| Time frame | Ever | Ever | Every two years | Every two years | Ever | Last 2 years |
|
| ||||||
| Study | Current study | Kwok et al. | Tang et al. | Kwok et al. | ||
| Country | Hong Kong | Hong Kong | United States | Australia | ||
| Targeted population | Chinese women with MI ≥20 years | Chinese women ≥40 years | Chinese-American women ≥60 years | Chinese-Australian women ≥40 years | ||
| Sample size | 310 | 320 | 100 | 158 | ||
| Screening rate | 36.5% | 37.8% | 70% | 35.4% | ||
| Time frame | Ever | Annually | Ever | Annually | ||
|
| ||||||
| Study | Current study | Abdullah et al. | Ma et al. | Breen et al. | ||
| Country | Hong Kong | Hong Kong | United States | United States | ||
| Targeted population | Chinese women with MI aged 21–65 years | Chinese women aged 31–50 years | Chinese-American women ≥18 years | Women ≥25 years | ||
| Sample size | 304 | 430 | NA | 15,704 | ||
| Screening rate | 40.5% | 59% | 72.1% | 79.9% | ||
| Time frame | Ever | Ever | Ever | Last 3 years | ||
|
| ||||||
| Study | Current study | Ma et al., | Breen et al. | McKinley et al. | ||
| Country | Hong Kong | United States | United States | Australia | ||
| Targeted population | Chinese men with MI ≥50 years | Chinese-American men ≥50 years | Men ≥50 years | Male BRCA1 and BRCA2 carriers aged 40–69 years | ||
| Sample size | 109 | 163 | 4,871 | 75 | ||
| Screening rate | 12.8% | 43.3% | 50.0% | 55% for PSA, 43% for DRE | ||
| Time frame | Ever | Ever | Last 2 years | Last 3 years | ||
|
| ||||||
| Study | Current study | Sung et al. | Ma et al. | Breen et al. | ||
| Country | Hong Kong | Hong Kong | United States | United States | ||
| Targeted population | Chinese men and women with MI ≥50 years | Chinese men and women aged 30–65 years | Chinese American men and women ≥50 years | Women ≥50 years | ||
| Sample size | 236 | 1,004 | NA | 11,679 | ||
| Screening rate | 21.6% | 9.9% | 34.7% | 30.2% for women, 37.1% for men | ||
| Time frame | Ever | Ever | Ever | Last 3 years | ||
* Only digital rectal examination was reported in the study
Abbreviations: MI = Mental illness; PSA = Prostate specific antigen test; DRE = Digital rectal examination; NA = Data not available
Knowledge and Perceptions about Cancer among People with Severe Mental Illness.
| Knowledge and perceptions | Total (%) |
| Do you think cancer in general can be cured if detected early? | |
| Yes | 482 (81.6%) |
| No/don't know | 109 (18.4%) |
| Do you know where you can get information on cancer or cancer services? | |
| Yes | 295 (49.9%) |
| No/don't know | 296 (50.1%) |
| Do you think cancer is caused by fate or higher power? | |
| Yes | 214 (36.2%) |
| No | 377 (63.8%) |
| Do you think that you can have cancer but not have symptoms? | |
| Yes | 399 (67.5%) |
| No/don't know | 192 (32.5%) |
| What do you think your risks are for developing cancer? | |
| Not at risk | 50 (9.4%) |
| Low/moderate risk | 401 (75.5%) |
| High risk | 80 (15.1%) |
| Do you think having a family member who has had cancer increases your risk of developing cancer? | |
| Yes | 372 (63.1%) |
| No/don't know | 218 (36.9%) |
Logistic Regression on Cancer Screening Behavior among People with Severe Mental Illness.
| Mammography | Clinical Breast Examination | Pap-smear Test | Prostate Examination | Colorectal Cancer Screening | |||||||||||
| (Female aged ≥40) (N = 236) | (Female aged ≥20) (N = 310) | (Female aged 21 to 65) (N = 314) | (Male aged ≥50) (N = 109) | (All aged ≥50) (N = 236) | |||||||||||
| Row% | ORU (95%CI) | ORM (95%CI) | Row% | ORU (95%CI) | ORM (95%CI) | Row% | ORU (95%CI) | ORM (95%CI) | Row% | ORU (95%CI) | ORM (95%CI) | Row% | ORU (95%CI) | ORM (95%CI) | |
|
| — | 1.02(.97–1.07) | — | — | 1.01(0.99–1.03) | — | — | 1.01(.99–1.04) | — | — | 1.04(.95–1.13) | — | — |
| — |
|
| |||||||||||||||
| Male | — | — | — | — | — | — | — | — | — | — | — | — | 21.3 | 1 | — |
| Female | 21.5 | 1.010.55–1.89) | |||||||||||||
|
| |||||||||||||||
| Primary School or below | 15.0 | 1 | — | 32.9 | 1 | — | 49.4 | 1 | — | 11.4 | 1 | — | 20.2 | 1 | — |
| Secondary School | 25.0 | 1.89(.92–3.89) | 36.0 | 1.15(.67–1.96) | 39.3 | .66(.40–1.11) | .90(.48–1.66) | 14.7 | 1.34(.39–4.61) | 22.0 | 1.12(.59–2.13) | ||||
| College or above | 13.3 | 0.87(.17–4.36) | 54.2 | 2.41(.96–6.05) |
|
| .41(.12–1.38) | 0 | — | 27.3 | 1.48(.36–6.10) | ||||
|
| |||||||||||||||
| Unemployed | 23.0 | 1 | — | 35.7 | 1 | — | 45.0 | 1 | — | 13.5 | 1 | — | 23.3 | 1 | — |
| Employed | 19.5 | 0.81(.43–1.54) | 36.9 | 1.05(.65–1.70) | 37.9 | .75(.47–1.21) | 12.7 | .93(.29–3.00) | 20.4 | .85(.45–1.60) | |||||
|
| |||||||||||||||
| Single | 14.1 | 1 | — | 27.1 | 1 | — | 19.7 | 1 | — | 12.1 | 1 | — | 20.4 | 1 | — |
| Married/Cohabited | 30.6 |
| 46.2 |
|
| 58.4 |
|
| 14.3 | 1.21(.32–4.55) | 20.9 | 1.03(.47–2.23) | |||
| Divorced/Separated/Widowed | 20.2 | 1.54(.69–3.43) | 40.8 |
| 1.58(.84–2.97) | 53.0 |
|
| 13.6 | 1.15(.27–4.91) | 23.1 | 1.17(.56–2.42) | |||
|
| |||||||||||||||
| $4000 or below | 19.6 | 1 | 33.6 | 1 | — | 36.7 | 1 | — | 11.8 | 1 | — | 22.1 | 1 | — | |
| $4000–$8000 | 27.5 | 1.56(.71–3.42) | — | 49.2 |
| 1.64(.87–3.12) |
|
| 1.50(.78–2.85) | 20.0 | 1.88(.52–6.74) | 25.0 | 1.18(.51–2.69) | ||
| $8000 above | 16.7 | .82(.09–7.26) | — | 42.9 | 1.48(.32–6.78) | 1.37(.20–9.39) | 71.4 | 4.32(.82–22.74) | 3.21(.54–19.08) | 0 | — | — | 0 | — | |
|
| |||||||||||||||
| Schizophrenia | 16.7 | 1 | — | 32.0 | 1 | — | 39.7 | 1 | — | 9.1 | 1 | — | 12.4 | 1 | — |
| Depression | 27.3 | 1.88(.90–3.91) | 43.2 | 1.62(.93–2.82) | 50.0 | 1.52(.88–2.63) | 11.8 | 1.33(.23–7.58) | 31.3 |
|
| ||||
| Bipolar Disorder | 17.6 | 1.07(.28–4.16) | 48.0 | 1.96(.82–4.70) | 40.0 | 1.01(.42–2.44) | 33.3 | 5.00(.38–65.36) | 30.0 | 3.04(.69–13.36) |
| ||||
| Others | 19.6 | 1.22(.49–3.01) | 30.9 | .95(.50–1.80) | 28.8 | .62(.32–1.17) | 15.6 | 1.85(.49–6.97) | 23.8 | 2.21(.96–5.12) |
| ||||
|
| |||||||||||||||
| No/don't know | 10.9 | 1 | — | 22.8 | 1 | 1 | 28.1 | 1 | — | 21.1 | 1 | — | 8.9 | 1 | 1 |
| Yes | 23.2 | 2.47(.92–6.64) | 39.5 |
| 1.54(.72–3.27) | 43.3 |
|
| 11.1 | .47(.13–1.69) | 24.2 |
|
| ||
|
| |||||||||||||||
| No/don't know | 22.9 | 1 | — | 32.7 | 1 | — | 41.6 | 1 | — | 10.2 | 1 | — | 19.7 | 1 | — |
| Yes | 18.1 | .74(.39–1.41) | 40.4 | 1.40(.88–2.22) | 39.3 | .91(.58–1.44) | 16.0 | 1.68(.54–5.23) | 23.5 | 1.25(.67–2.33) | |||||
|
| |||||||||||||||
| No/don't know | 17.7 | 1 | — | 39.0 | 1 | — | 44.2 | 1 | — | 9.1 | 1 | — | 21.1 | 1 | — |
| Yes | 25.3 | 1.57(.83–2.95) | 32.2.74(.46–1.21) | 34.2 | .66(.41–1.06) | 18.6 | 2.29(.73–7.13) | 21.6 | 1.03(.55–1.94) | ||||||
|
| |||||||||||||||
| No | 14.9 | 1 | — | 17.7 | 1 | — | 21.1 | 1 | — | 11.1 | 1 | — | 18.3 | 1 | — |
| Yes | 23.5 | 1.76(.84–3.67) | 44.9 |
|
| 49.3 |
|
| 13.7 | 1.27(.37–4.37) | 22.9 | 1.33(.68–2.60) | |||
|
| |||||||||||||||
| Not at risk | 14.3 | 1 | — | 18.5 | 1 | — | 37.0 | 1 | — | 0.0 | — | — | 17.6 | 1 | — |
| Low/moderate risk | 19.2 | 1.43(.39–5.17) | 40.0 |
| 2.18(.73–6.49) | 39.8 | 1.12(0.49–2.58) | 12.0 | 21.9 | 1.31(.36–4.80) | |||||
| High risk | 32.4 | 2.88(.71–11.71) | 41.7 |
| 2.08(.61–7.11) | 45.8 | 1.44(0.55–3.78) | 23.1 | 24.2 | 1.49(.34–6.56) | |||||
|
| |||||||||||||||
| No/don't know | 20.3 | 1 | — | 25.0 | 1 | — | 30.2 | 1 | — | 5.7 | 1 | — | 18.1 | 1 | — |
| Yes | 21.0 | 1.05(.54–2.05) | 42.1 |
| 1.48(.79–2.77) | 45.4 |
|
| 18.2 | 3.70(.96–14.31) | 24.1 | 1.43(.76–2.71) | |||
|
| — | 1.28 (.95,1.75) | — | — |
|
| — |
|
| — | 1.16 (.75–1.79) | — | 1.26 (.90–1.77) | ||
*p<.05,
**p<.01,
***p<.001, Abbreviations: ORU = odds ratio obtained using univariate logistic regression, ORM = odds ratio obtained from stepwise multivariate logistic regression analysis using univariately significant variables as candidate variables; CI = confidence interval;
— not applicable.